Severe pulmonary hypertension in COPD: Is it a distinct disease?

Chest

Volumn 127, Issue 5, 2005, Pages 1480-1482

  Weitzenblum, Emmanuel ^a,b,c   Chaouat, Ari ^a,c  

^a Hôpitaux Universitaires de Strasbourg ^*

^b UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^c HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN RECEPTOR ANTAGONIST; PHOSPHODIESTERASE INHIBITOR; PROSTANOID; VASODILATOR AGENT;

ARTERIAL GAS; BLOOD PRESSURE MEASUREMENT; BRONCHUS OBSTRUCTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; EDITORIAL; HEART CATHETERIZATION; HUMAN; HYPOXEMIA; HYPOXIA; LUNG ARTERY PRESSURE; LUNG SURGERY; LUNG TRANSPLANTATION; OXYGEN THERAPY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; THROMBOEMBOLISM; ANOXIA; LUNG; NOTE; PATHOPHYSIOLOGY;

ANOXIA; HUMANS; HYPERTENSION, PULMONARY; LUNG; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 19844371035     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.127.5.1480     Document Type: Editorial

References (23)

1. Fishman AP. Chronic cor pulmonale. Am Rev Respir Dis 1978; 114:775-794
2. Bishop JM. Cardiovascular complication of chronic bronchitis and emphysema. Med Clin North Am 1973; 57:771-780
3. Weitzenblum E. Chronic cor pulmonale. Heart 2003; 89:225-230
4. Hatano S, Strasser T, eds. Primary pulmonary hypertension: report on a WHO meeting. Geneva, Switzerland: World Health Organization, 1975; 7-45
5. Simonneau G, Galié N, Rubin LJ, et al. Clinical classification of pulmonary hypertension. Am J Coll Cardiol 2004; 43:5S-12S
6. Weitzenblum E, Hirth C, Ducolone A, et al. Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease. Thorax 1981; 36:752-758
7. Scharf SM, Iqbal M, Keller C, et al. Hemodynamic characterization of patients with severe emphysema. Am J Respir Crit Care Med 2002; 166:314-322
8. Chaouat A, Schott R, Kessler R, et al. Severe pulmonary hypertension in chronic obstructive pulmonary disease [abstract]. Am J Respir Crit Care Med 2003; 167:A696
9. Abraham AS, Cole RB, Green ID, et al. Factors contributing to the reversible pulmonary hypertension of patients with acute respiratory failure studied by serial observations during recovery. Circ Res 1969; 24:51-60
10. Grover RF. Chronic hypoxic pulmonary hypertension. In: Fishman AP, ed. The pulmonary circulation: normal and abnormal. Philadelphia, PA: University of Pennsylvania Press, 1990; 28:3-299
11. Ashutosh K, Mead G, Dunsky M. Early effects of oxygen administration and prognosis in chronic obstructive pulmonary disease and cor pulmonale. Am Rev Respir Dis 1983; 127:399-404
12. Weitzenblum E, Schrijen F, Hohan-Kumar T, et al. Variability of the pulmonary vascular response to acute hypoxia in chronic bronchitis. Chest 1988; 94:772-778
13. Eddahibi S, Chaouat A, Morrell N, et al. Polymorphism of the serotonin transporter gene and pulmonary hypertension in chronic obstructive pulmonary diseases. Circulation 2003; 108:1839-1844
14. Ourednik A, Susa Z. How long does the pulmonary hypertension Last in chronic obstructive bronchopulmonary disease? In: Widimsky, ed. Progress in respiration research: pulmonary hypertension. Basel, Switzerland: Karger, 1975; 24-28
15. Bishop JM, Cross KW. Physiological variables and mortality in patients with various categories of chronic respiratory disease. Bull Eur Physiopathol Respir 1984; 20:495-500
16. Oswald-Mammosser M, Weitzenblum E, Quoix E, et al. Prognostic factors in COPD patients receiving long-term oxygen therapy. Chest 1995; 107:1193-1198
17. Timms RM, Khaja FU, Williams GW, et al. Hemodynamic response to oxygen therapy in chronic obstructive pulmonary disease. Ann Intern Med 1985; 102:29-36
18. Weitzenblum E, Sautegeau A, Ehrhart M, et al. Long term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1985; 131:493-498
19. Medical Research Council Working Party. Long-term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema: report of the Medical Research Council Working Party. Lancet 1981; 1:681-686
20. Zielinski J, Tobiasz M, Hawrylkiewicz I, et al. Effects of long-term oxygen therapy on pulmonary hemodynamics in COPD patients: a 6-year prospective study. Chest 1998; 113:65-70
21. Badesch DB, McLaughlin VV, Delcroix M, et al. Prostanoid therapy for pulmonary arterial hypertension. J Am Coll Cardiol 2004; 43:56S-61S
22. Channick RN, Sitbon O, Barst RJ, et al. Endothelin receptor antagonists in pulmonary arterial hypertension. J Am Coll Cardiol 2004; 43:62S-67S
23. Ghofrani HA, Pepke-Zaba J, Barbera JA, et al. Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension. J Am Coll Cardiol 2004; 43:68S-72S